Abstract
Commentary on the ANNEXA-I trial from the guideline group of the European Society of Anaesthesiology and Intensive Care (ESAIC) on the reversal of direct oral anticoagulants in patients with life threatening bleeding.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have